Reports
The following list of reports reflects the latest in findings and outcomes in medical research as presented at major medical meetings and published peer-reviewed medical journals. In this section you can view reports from important congresses as well as summaries of some recently published journal articles. Please let us know if you have a particular area of interest you would like to see covered.
PRIORITY PRESS - American Transplant Congress 2009
Preservation of Long-term Renal Function in Transplant Patients: Role of Once-daily CNI Dosing
Boston, Massachusetts / May 30-June 3, 2009
Boston - Findings from a 10-year follow-up of renal transplant patients originally randomized in a comparison of the two calcineurin inhibitors (CNIs) suggest that CNI-sparing regimens are not necessarily essential for better long-term...
PRIORITY PRESS - 29th Annual Meeting and Scientific Sessions of the International Society for Heart and Lung Transplantation
Immunosuppression in Heart Transplant Patients at High Risk for Poor Outcomes
Paris, France / April 22-25, 2009
Paris - The field of heart transplantation was revolutionized in the 1970s by the introduction of safer and more effective immunosuppressive regimens that significantly increased the chances that cardiac graft recipients could survive for...
MEDICAL FRONTIERS - 35th Annual Meeting of the European Group for Blood and Marrow Transplantation
Secondary Prevention of Invasive Fungal Infections in Stem-cell Transplant Patients
Göteborg, Sweden / March 29-April 1, 2009
Göteborg - The risk of recurrence of a previous invasive fungal infection (IFI) or acquisition of a new one is a major obstacle to the success of stem-cell transplantation (SCT). These infections are increasing in frequency and the majority...
ABSTRACTS in PERSPECTIVE based on presentations from the American Transplant Congress 2008
Preserving Renal Function: Exploring Calcineurin Inhibitor-sparing Regimens in Renal Allograft Recipients
May 30-June 4, 2008 / Toronto, Ontario
EDITORIAL OVERVIEW R. Jean Shapiro, MD, ABIM, FRCPC Medical Director, Renal Transplantation Medical Manager, Solid Organ Transplantation Vancouver General Hospital Clinical Associate Professor of Medicine University of British...
45th Annual Congress of the European Renal Association (ERA)/European Dialysis and Transplant Association (EDTA)
Chronic Kidney Disease: New Strategies to Reduce Phosphate Burden
Stockholm, Sweden / May 10-13, 2008
Stockholm - Disorders of mineral metabolism are linked to cardiovascular (CV) morbidity and mortality in patients with chronic kidney disease (CKD) who are on dialysis. Above all, hyperphosphatemia is associated with the development of CV...
40th Annual Meeting and Scientific Exhibition of the American Society of Nephrology
Hyperphosphatemia and the Dialysis Patient: Focus on Reducing Calcification
San Francisco, California / November 2-5, 2007
San Francisco - Elevated phosphorus levels occurring at kidney failure are associated with increased vascular calcification and cardiovascular events. Presently, in dialysis patients, hyperphosphatemia is usually managed with phosphate...
13th Congress of the European Society for Organ Transplantation
Simplifying Immunosuppression in Post-transplant Patient Management
Prague, Czech Republic / September 29-October 3, 2007
“In our literature review, we found that 40% to 60% of all late acute rejections are due to non-adherence,” stated Dr. Fabienne Dobbels, Catholic University of Leuven, Belgium. “The incidence of late acute rejection in the...
44th European Renal Association/European Dialysis and Transplant Association Annual Congress
Balancing Needs and Concerns of Dialysis Patients: Simplified Regimens, Enhanced Patient Compliance
Barcelona, Spain / June 21-24, 2007
Barcelona - About one-third of patients with any chronic condition fail to adhere to their medical regimen as prescribed. Non-adherence is a variable behaviour and is rooted in a patient’s pre-existing set of beliefs about how important a...
American Transplant Congress 2007
Low-dose Immunosuppressive Regimens: Lessons from SYMPHONY
San Francisco, California / May 5-9, 2007
San Francisco - The large multicentre SYMPHONY study was carried out in 1645 de novo renal transplant recipients. A standard immunosuppressive regimen containing the calcineurin inhibitor cyclosporine, mycophenolate mofetil and steroids was...